Oncolytics Biotech Inc T.ONC

Many unknowns, one thing we know for sure

[canadafan]

In the past week, or so there have surfaced many corporate changes/ modifications.
Andew D is gone. Perhaps fired, quit, we don't know.
A new scientific advisory committee member has been added.
Now a posting for a " medical writer" 
Options available, no solid conclusions yet if Matt utilized or not. That reporting is due next few days.
These are all significant corporate changes. 
I agree hiring a medical writer indicates plans to ramp up for something.

Imho, weekend comentsry
 
Those who have been around longer than a few years, know full well.
1. Onc has mutiple sucsesses with Roche. Aka Goblet trials. 3 out if 4 arms, yeilded well above standard of care resukts.
2. They have answered every possible question, pre- phase 3 for MBc & Pancreatice cancer.
3. The PanCan approval was pulled, not of anything to do with Onc, but PanCan delays of federal funding. Yet they still committed to the $5million grant. To add an additional arm, for Pancreatic cancer.
4. There are more than 3 lower attention opportunities, not dead, but not being discussed.
Car-t , being one.
conclusion, on the science side they have carried the ball as far as it can go.
Now it's time to make a deal & move forward.

Again anyone around for a few years or more can agree.
Management knows that The B.O.D. Knows that.
All the analysts know that.

Observationalky ?

Very strange management changes. Anyone can spin the information anyway you want.
My bottom line?
They are in process of changing for a better future. You. Don't add positions if the company sees trouble ahead.
The phase 3 trial(s) will start.How & with who? We will see soon.

On the $$ side of Things? Corporate structure. Share dillution etc etc.?
im still of the opinion a buyout is the best option at this time.
Regardless of any speculations, we will know a lot more before year end.
At this stage, nothing would surprise me.
Best of health & wellbeing all the Onc chat folks. Let's hope 2024 is better than 2023.

[fox7mf]

All the best to you & yours for the holiday season and beyond Canadafan, and thanks for your contributions. 

[itntdf]

as the president of oncolytics biotech u.s. (obus), it seems odd there is no filing about his departure if he is indeed gone. interestingly, on nov. 17 he exercised his option to purchase 100,000 share at $1.45/share bringing his total holdings to just under 500k shares. and, if he is gone, who is the current president of obus, or where is that slot shown as open? seems odd.

[lonc17]

Itntdf, Andrew De G. did in fact exercise his options last month, but there was a data entry omission in SEDI. He should have recorded -100,000 for his options and then shown a corresponding +100,000 for ownership of common shares. This would bring his total holdings of common shares to 110,315, not the half million or so that you had noted (those were his unexpired options before exiting the

[lonc17]

The share price continues to drop but miraculously it remains above $1.45 CDN. MC refused the opportunity to buy shares at $1.45 CDN. ONC's CEO believes that at $1.45 CDN his own company is over valued. 

[fox7mf]

Hey Canadafan, I read your recent post on Yahoo suggesting investors watch for a big surprise concerning Oncy during the first week of Jan. I too believe something BD wise has to give soon, and as usual, your optimism is appreciated. Fingers crossed on that huge news, and merry merry to you, yours and all Oncy investors. We're due. 

[Azzak34]

This post has been removed in accordance with Community Policy

[Azzak34]

This post has been removed in accordance with Community Policy

[Buckhenry]

Well we can be assured nothing will happen this first week now. Thanks canuckfan for ur "insider"  info.